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INTRODUCTION
Transfer ribonucleic acid (tRNA) synthetases play an important role in the central dogma of molecular biology. The specific function of tRNA synthetases is to conjugate tRNAs with the cognate amino acid for correct translation of polypeptides from mRNA. Progressively, highly conserved and non-canonical activities of tRNA synthetases that are unique for each amino acid-charging tRNA synthetase have been discovered. Lysyl-tRNA synthetase (LysRS), a tRNA that charges lysine onto lysine-tRNA for use in ribosome for translation, have also been serving an evolutionarily conserved, non-canonical enzymatic activity to produce diadenosine tetraphosphate (Ap 4 A), a small signaling molecule composed of two adenosine moieties joined through a 5 0 -5 0 linkage by a chain of four phosphates. This non-canonical pathway in LysRS is triggered by the phosphorylation of LysRS on serine 207 (P-s207 LysRS) via p38 mitogen-activated protein kinase activity. Phosphorylation leads to the dissociation of P-s207 LysRS from multi-synthetase complex (MSC) and promotes the production of Ap 4 A (Ofir-Birin et al., 2013) . In turn, the synthesis of Ap 4 A is regulated by the housekeeping protein Ap 4 A hydrolase (Ap 4 AHy) that converts Ap 4 A back into its original building blocks (one molecule of ATP and one molecule of AMP) thereby creating a regulatory feedback to maintain intracellular Ap 4 A levels (Vollmayer et al., 2003) .
Ap 4 A synthesis activity by LysRS can directly control specific response programming in immune-specialized cells (Nechushtan et al., 2009) . Our group has previously demonstrated that non-canonical LysRS activity can drive increased intracellular Ap 4 A and control USF2 transcriptional activity, which up-regulates transforming growth factor-b2 in FcepsilonRI-activated mast cells (Lee and Razin, 2005) . Ap 4 A can enhance phorbol myristate acetate (PMA)-stimulated reactive oxygen species production in lymphocytes (Schepers et al., 2010) and has been implicated in key immunological responses (Carracedo et al., 2013; Castany et al., 2011; Chang et al., 2014; Louie et al., 1988) . Another pathway that is driven by the increase of intracellular Ap 4 A is the activation of microphthalmia-associated transcription factor (MITF), a master regulator in melanocyte development (Levy et al., 2006) . Hint1, a co-suppressor of MITF, is also inactivated by high intracellular concentration of Ap 4 A and dissociates from Hint1. Released MITF can translocate to the nucleus and initiate transcription of downstream genes (Lee et al., 2004a) .
Ap 4 A is also implicated in the control of antigen presentation. Low levels of Ap 4 A are observed in patients with Chediak-Higashi syndrome (Kim et al., 1985) , where delayed major histocompatibility complex (MHC) class II-restricted antigen presentation increases pathogen load (Martin-Ferná ndez et al., 2005) . The expression of MHC class II is a defining feature of antigen-presenting cells (APCs). Among APCs, dendritic cells (DCs) possess vastly efficient antigen cross-presentation response over all other known immune cell types. DCs possess high motility to bring sampled antigens to naive T cells located in lymph nodes to stimulate adaptive immune response. Hence DCs act as connecting linkers between innate and acquired immunity. Immature DCs, although present in blood, are more prevalent in pathogen-prone peripheral tissues. Mature DCs travel toward lymph nodes for the antigen presentation to T and B cells, thus activating acquired immune response (Clark et al., 2000) . Harnessing the ability of DC as a professional APC to enhance antigen-specific T cell immune response with high precision is particularly useful for the development of more effective cancer immunotherapy vaccines (Zamarin and Postow, 2015) .
DCs adopt a dynamic behavior by migrating to lymph nodes for naive T or B cell priming and maintaining acquired immune activity (Germain et al., 2012) . Hence migratory ability of DC is directly correlated with its ability to stimulate immune response through antigen presentation to naive T and B cells in remotely accessible regions of lymph nodes awaiting stimulation by DCs.
We reasoned that if a highly conserved function of APCs such as antigen presentation can be precisely impaired by low levels of intracellular Ap 4 A, APCs may functionally benefit from the increase of intracellular Ap 4 A concentration. We hypothesized that Ap 4 A is able to enhance functional capacities of APCs by improving either mobility or antigen presentation, or both. Figure 1D ).
Based on the increased cellular permeability and binding ability with free amines retained in dead cells than live cells, saturation of cells with amines conjugated to florescent APC-Cy7 probe were measured by using flow cytometry to determine the live and dead cell population percentages. (2.3-and 3.2-folds, respectively), whereas the levels reached peak state on eighth day of culture (approximately 32-fold; Figure 2A ).
Another correlative activation from the increase in intracellular Ap 4 A concentration is the initiation of LysRSAp 4 A-Hint1-MITF pathway. The MITF nuclear localization was examined in splenic DCs and was detected prominently (without concomitant increase in expression) in splenic Nudt2 fl/fl /CD11c + cells, but not in Figure 2B ). Furthermore, Hint1, a suppressor of MITF, is not present in the nucleus of matured DCs and monocytes and is only present in unmatured BM cells. Hint1 translocation also posits that MITF suppression is released from increased Ap 4 A concentration within Nudt2 fl/fl /CD11c + splenic cells.
To validate the translocation of MITF in to nucleus, which leads to gene transcription, MITF-specific gene tartrate-resistant acid phosphatase 5 (TRACP5) was examined for expression (Luchin et al., 2010 Figure 2C) . To review the association of MITF with LysRS, which occurs during activation of MITF, a pull-down of MITF using LysRS antibody via co-immunoprecipitation experiment was performed on BMDCs. MITF is co-immunoprecipitated using LysRS antibody pull-down in both Nudt2 +/+ and Nudt2 fl/fl DCs, indicating the that binding of LysRS to MITF occurs at baseline level in DCs and the association is increased in Nudt2 fl/fl DCs ( Figure S1 ). 3D ). Less directional variability indicates enhanced organization of cytoskeletal dynamics, and such organization generally requires the activation of small GTPases, such as Rho GTPases. The Rho GTPases play a crucial role in cellular migration, of which Rho, Rac, and Cdc42 are widely studied proteins and are highly conserved among eukaryotes (Ridley, 2015) . To examine a possible relationship between intracellular Ap 4 A increase in DCs and small GTPase activation, active Rac1, cdc42, and RhoA levels were measured (GTP-bound form). The results show a significant decrease in active Rac1 and cdc42, and an increase in RhoA activation levels in case of BMDCs of Nudt2 fl/fl /CD11c + mice compared with that of Nudt2 +/+ CD11c + mice ( Figure 3E ).
Nudt2
fl/fl /CD11c + DCs Possess Higher Antigen-Presenting and CD8 + T Cell-Priming Potential
The possibility of NUDT2 gene directly controlling fundamental immune activity of DCs was also investigated. It is equally important to know whether Nudt2 is important for DC maturation because its status directly impacts the immune function as APCs. Although DCs are highly specialized immune cells that specialize as APCs, they are initially phagocytic before maturation. A change in phagocytic potential would indicate aberrant DC maturation signaling compared with Nudt2 +/+ DCs. To measure the phagocytic potential, uptake of fluorescein isothiocyanate (FITC) dextran by DCs was measured. The phagocytic potential of DCs of Nudt2 fl/fl /CD11c + mice was found to be unchanged when compared with that of Nudt2 +/+ DCs as the uptake of FITC dextran DCs from Nudt2 fl/fl /CD11c + mice was identical to Nudt2 +/+ DCs both at 4 C and 37 C ( Figure S2 ). Therefore, these DCs do not differ in phagocytic capacity, a defining attribute in DC maturation status, indicating that DC maturation status is identical. To determine if antigen presentation functionality is affected, the capacity of DCs to trigger proliferation in antigen-specific T cells that requires DCs to present highly specific antigens to these T cells to trigger activation and proliferation was also investigated. The cultures of BMDCs from either the Nudt2 fl/fl /CD11c + or the Nudt2 +/+ /CD11c + mice incubated with OT-1 T cell were co-incubated with positive control SIINFEKL peptides, and have given a similar extent of stimulation of proliferation of CD8 + T cells, indicating an overall lack of involvement in the activation of T cells by DCs, which does not require antigen cross-presentation (Figures 4A and 4B) . Remarkably, when cultured with DCs co-incubated either with whole ovalbumin (OVA) or OVA and cytosine-phosphodiester linked guanine ligodeoxynucleotides (CpG ODN), there was an average of 20% and 15% higher stimulus in the proliferation of CD8 + T cell population, respectively, by the BMDCs from Nudt2 fl/fl /CD11c + mice compared with the Nudt2 +/+ BMDCs. Nudt2 gene is therefore involved in the control of antigen cross-presentation machinery in DCs.
To determine the involvement of interleukin (IL)-12 p40, which is a DC-specialized T cell activation cytokine that controls enhancement of antigen cross-presentation by Nudt2 fl/fl /CD11c + BMDCs, the cytokine levels were measured by ELISA technique. The results revealed a lack of involvement of IL-12 p40 in enhancing the priming of CD8 + T cells by Nudt2 fl/fl /CD11c + BMDCs as there was no observable difference in the levels of IL-12 p40 between Nudt2 fl/fl /CD11c + BMDCs and Nudt2 +/+ BMDCs ( Figure 4C ).
Antigen cross-presentation can also be skewed by the change in expression of TAP proteins required for assembly of short peptides onto MHC-I molecules. The mRNA levels of TAP1, TAP2, and TAPASIN were measured in Nudt2 fl/fl /CD11c + DCs as well as in Nudt2 +/+ DCs. The results have shown a lack of difference in TAP1, TAP2, or TAPASIN between Nudt2 fl/fl /CD11c-cre or Nudt2 +/+ DCs indicating lack of their involvement ( Figure 4D ). Taken together, Nudt2 gene is involved in controlling antigen cross-presentation machinery that directly signals T cell proliferation.
DISCUSSION
This study shows that intracellular Ap 4 A can be upregulated in immune cells of a specific lineage (DCs) within an in vivo model. The DCs from these mice are lacking Ap 4 A hydrolase, and a consequent rise in intracellular Ap 4 A amounts is observed, revealing an obvious substantial regulation of Ap 4 A concentrations in DCs by Ap 4 A hydrolase through the NUDT2 gene. The Nudt2 fl/fl /CD11c + mice did not exhibit any observable physiological differences to wild-type, leading to the inference that they harbor similar small population of CD11c + cells as are normally present. In addition, their viability remained almost similar.
DCs play a pivotal role in adaptive immunity and tolerance. Efficient migration for accurate positioning to capture antigens from invading pathogens and capacity to process the foreign peptides into recognizable MHC-I-bound complexes through antigen-cross presentation are two immutable purposes of DCs. These functions are therefore critical for immune protection. Most of the immature and highly phagocytic DCs begin their voyage from the bone marrow where they are generated, followed by entry into the blood and sequential movement into peripheral lymphoid tissues (PLTs) and non-lymphoid tissues (NLTs). The DCs possess advanced migratory skills, and their main function in NLTs is the carriage and presentation of antigenic components into and within secondary lymphoid organs (Alvarez et al., 2008) . Once primed by the phagocytosis of foreign antigens the enrouted Ag-bearing DCs in lymph nodes begin to build up an immune-stimulatory phenotype, exhibiting increased expression of MHC complexes as well as upregulation of the co-stimulatory molecules and cytokines required for effective T cell priming. The non-retained DCs enter into the blood stream (blood-borne DCs) and deliver the antigenic components to the spleen (Mullins et al., 2003) and also to PLTs (Cavanagh et al., 2005) .
The relationship between Nudt2 and DC is unknown, but its association with immune function has been speculated. A recent RNA sequencing analysis of Nudt2 knockout myelogenous leukemia cells revealed that the majority of the target genes are linked to immune-specific processes such as interferon-associated inflammatory responses, MHC-II antigen presentation, allograft rejection, and B cell development (Marriott et al., 2016) . The current study focused on the influence of Ap 4 A over immune activity of DCs from Nudt2 fl/fl /CD11c + mice and has confirmed that Nudt2 gene has influence over MHC-II antigen presentation.
Ap 4 A regulates MITF activation through the release of Hint1 suppression and consequent nuclear localization of MITF. The nuclear localization of MITF, as a result of increase of Ap 4 A, is a hallmark of the LysRSAp 4 A-Hint1-MITF pathway (Carmi- Levy et al., 2008; Huete et al., 2011; Lee and Razin, 2005; Lee et al., 2004b; Tshori et al., 2013) . The LysRS-Ap 4 A-Hint1-MITF pathway has been described in mast cells (Lee et al., 2004a) , but it was not clear whether the same pathway is active in DCs.
The LysRS-Ap 4 A-Hint1-MITF pathway was examined in DCs in this study, and it was revealed that the increase in MITF nuclear localization, but not HINT-1, in response to the elevated Ap 4 A levels is due to the knockout of NUDT2 gene. The binding of MITF to LysRS using co-immunoprecipitation pull down of MITF using LysRS antibody establishes the existence of LysRS-Ap 4 A-Hint1-MITF pathway in DCs and further confirms that Hint1 suppression is lifted so that LysRS can bind active MITF.
The BMDCs from Nudt2 fl/fl /CD11c-cre mice cultured from undifferentiated monocytes did not show any morphological or phenotypic differences to Nudt2 +/+ DCs. Interestingly, the DCs of Nudt2 fl/fl /CD11c + mice exhibited a unique pattern of cellular motility with higher velocity and lower directional variability. This suggests that the majority population of DCs of Nudt2 fl/fl /CD11c + mice is having uniform directional imprint that may indicate effective migration toward the immune reaction zones. Furthermore, we found such behavior was correlated to the variation in their expression of small GTPases, i.e., cdc42, Rac1, and RhoA. Our findings provide evidence that reduced activation of Rac1 in DCs leads to increased directional motility, consistent with the earlier studies over fibroblasts that had shown their enhancement of directional motility by the inactivation of the same GTPases (Hanna and El-Sibai, 2013 ). Among small GTPases that are important in cell motility, Rho GTP is critical for inducing actomyosin contraction and inhibiting actin filament disassembly for cell polarity and directional migration (Kimura et al., 1998; Maekawa et al., 1999 (Ohta et al., 2006) , and this is likewise also observed in CD11c + DC derived from Nudt2 fl/fl mice.
The defining feature of DCs is their ability to take up antigen in the periphery, through their dendrites; to withdraw those dendrites; and then to migrate to lymph nodes. Upon regaining their former shapes in lymph node, DCs will present antigenic peptides to CD4 + and CD8 + T cells. Thus DCs may be regarded as the ''shape-shifters'' of the immune system. Cross-presentation is the intracellular degradation of extrinsic antigen and its presentation by MHC-I. This important DC function activates CD8 + T cells during an immunological response to intracellular pathogens (Murphy and McLennan, 2004; Murphy et al., 2000) and is a highly energy-dependent process and requires movement of the cells into finding suitable T cells. Though identical levels of phagocytic potential, Class-II MHC display and expression of co-stimulatory molecules were seen in DCs of Nudt2 fl/fl /CD11c + mice, there was an enhancement in their immune functionality. These DCs have increased immune activity in terms of antigen processing and cross-presentation in priming the proliferation of CD8 + T cells. In vitro antigen presentation assay using OT-1 CD8 + T cells is well suited to validate this result as an antigen-specific response. The activation of CD8 + T cells of OT-1 mice is exclusive for antigen presentation of OVA through DC cross-presentation machinery, and the subsequent trigger of proliferation in OT-1 CD8 + T cells is a highly specific response against cross-presented MHC-I antigen on APCs. CD11c + DC derived from Nudt2 fl/fl mice are capable of driving the proliferation of antigen-specific CD8 + T cells without the need for CpG ODN, a potent immune agonist (Ramírez-Pineda et al., 2004) . However, this observation was found not associated with the expected alteration in the elements of MHC-I machinery, reflecting the possible positive influence of directional motility making effective contact to the T cells and also the rise in the duration of functioning in antigen presentation process. There is direct evidence in support of one of our assumption.
Other groups have also reported that overexpression of Rho can directly increase the ability of DC to present OVA peptide to specific T cells (Shurin et al., 2005) . Our studies indicate that the increased CD8 + T cell cross-priming potential of DC from Nudt2 fl/fl /CD11c + mice compared with Nudt2 +/+ is more likely the result of RhoA activation and RAC1 repression. This is in agreement with the earlier studies (Hanna and El-Sibai, 2013; Shurin et al., 2005; Wu et al., 2009 A hydrolase and enhancing antigen cross-presentation by DC. Fundamentally, enhanced antigen cross-presentation in a controlled manner will benefit a wide variety of APC-associated functions such as earlier pathogen recognition by the immune system and better loading and presentation of tumor antigens to cytotoxic CD8 + T cells in response to cancer. The highly specific control of intracellular Ap 4 A concentration through manipulation of NUDT2 gene makes this mechanism an attractive pharmacological target to enhance antigen presentation while keeping the complex repertoire of transcriptional activation of APCs as intact as possible.
Limitations of the Study
The currently studied Nudt2 fl/fl /CD11c + mice model is an excellent in vivo system to understand the consequences of increased intracellular Ap 4 A. It is important and yet to be determined whether the circulatory DCs in Nudt2 fl/fl /CD11c + mice exhibit elevation in antigen presentation to T cells. Also, the identification of key cytokines responsible for DC-specialized T cell activation would become significant. In addition, this study necessitates the elucidation of Ap 4 A-binding proteins that are associated with cellular migration in future.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
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Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.05.045.
ACKNOWLEDGMENTS
The present study was supported in part by grants from the National University of Singapore to D.M.K.; Israel Science Foundation, 115/2013, and Hebrew-University-National Research Foundation of Singapore HUJ-CREATE (R182-005-172-281) to E.R. Graphical abstract was created with bio-render.com. 
AUTHOR CONTRIBUTIONS
Transparent Methods
Materials and methods
Mice
The C57BL/6 mice (8-10 weeks old) and OT-1 mice were purchased from National University of Singapore CARE and Charles River Laboratories, respectively, and were bred at NUS CARE. Nudt2 fl/fl mice were generated by OZ-gene. CD11c-cre transgenic (C57BL/6 CD11c-cre ) mice were gifted from 
Diadenosine nucleotide assay
The nucleotide assay detects the amount of Ap4A present in extracts of mammalian cells. For each determination, bone marrow cells were seeded at a density of 2 x 10 6 cells per well and cultured for 7 days in accordance to the method outlined in methods section 1.6 (generation of BMDCs). For the generation of BMDCs, cells in one well of a 6-well plate was grown for 3 to 8 days as specified. The cell layer was washed with warm serum-free medium and lysed with 0.4 M trichloroacetic acid. The extraction cum measurement of the nucleotides using luminometry was performed as described previously .
Quantitative polymerase chain reaction (qPCR)
Total RNA was isolated from sorted splenic DCs using the RNeasy kit (Qiagen, CA, USA), followed by cDNA synthesis using QuantiTect Reverse
Transcription kit (Qiagen). Both kits were used according to manufacturer's instructions. Real-time PCR was performed on an ABI7500 real-time PCR system using SYBR Green (Applied Biosystems Pte Ltd, Singapore 
Western Blotting
Following experimental treatment, cells were washed with ice-cold PBS, pelleted and re-suspended in RIPA lysis buffer (Sigma Aldrich, Singapore)
supplemented with 1X complete protease inhibitor cocktail (Roche Ltd, Singapore). The supernatant was collected for SDS-PAGE analysis. Laemmli sample buffer (Bio-Rad, USA) was used to load proteins onto SDS PAGE gel.
Equal amounts of protein from each sample were subjected to 15% SDS-PAGE at a constant voltage (125V) using mini-PROTEAN system (Bio-Rad Laboratories, Singapore). The proteins on SDS-PAGE gels were transferred onto Immun-Blot PVDF membrane (Bio-Rad, USA) using Trans-blot Turbo (Bio-Rad Laboratories, Singapore) according to manufacturer's protocol.
Antibodies from Cell Signaling Technologies (USA) for western blot were:
LysRS, MITF, Hint1, Histone H2A.X and α-tubulin. Ap4A Hydrolase antibody was from Santa Cruz Biotechnology, USA. MetaMorph NX (version 2.5) was used to capture the image and process for image analysis and post-processing of image was done with Fiji ImageJ (Schindelin et al., 2012) . To determine the motility of each cell, a specific position within the centre of nucleus using Manual Track plug-in for ImageJ (National Institute of Health, USA) analysis by frame-for-frame assigning tracker with tracer on an exact point in the nucleus over at least 20 frames was accomplished.
Generation of BMDCs
To generate BMDCs, the tibia and femur of mice were excised and the cells were suspended in RPMI containing 1% Hyclone Fetal Calf Serum (GE Healthcare, Singapore). After passing the cell suspension through 0.70 μm cell strainer (Thermo Fisher, Singapore) cells were pelleted (centrifugation at 300g for 7 min) and allowed for red blood cell lysis. The bone marrow cells were cultured at a concentration of 1 x 10 6 cells/ml in RPMI with 10% FCS, 1% non-essential amino acid (Sigma Aldrich), 1mM Sodium pyruvate (Sigma Aldrich), 5µM β-Mercaptoethanol (Sigma Aldrich), 100 IU/ml Penicillin (Sigma Aldrich), 0.1 mg/ml Streptomycin (Sigma Aldrich), and 5 ng/ml GM-CSF in 6-well plates. Cells were incubated in a humidified incubator at 37°C, 5% CO2. On day 2, 4 and 6, 75% of volume in medium was replaced with fresh medium supplemented with GM-CSF (5 ng/ml). After 7 days, the non-and loosely-adherent cells were harvested, washed, and magnetically isolated for CD11c positivity using anti-CD11c-conjugated MACS beads (Miltenyl Biotec, USA). Flow-through or non-CD11c + cells were also collected as CD11c -cells as a control. The BMDCs were routinely examined and was CD11c + (high) MHC class II + (>90%).
Cell isolation
To isolate naïve CD8 + T cells from OT-1 mice, spleens were collected from euthanized mice. Single-cell suspensions were layered on Ficoll-Paque (GE Healthcare, Singapore) and centrifuged at 600 g for 20 min. Cells accumulating at the interface were collected, washed twice with MACS buffer and incubated with anti-CD8α-conjugated magnetic cell sorting (MACS) beads (Miltenyi Biotec Pte Ltd, Singapore). Then the cells were isolated by passing through a MACS column. To isolate splenic DCs from Nudt2 fl/fl mice and Nudt2 +/+ c57bl/6 mice spleens were perfused and digested with Liberase Cl (Roche) for 30 min at 37°C. Single-cell suspensions were reconstituted with Optiprep (Sigma Aldrich) diluted to 1.062 g/ml and subjected to density centrifugation at 1700g, 10 min at 4°C.
Low-density cells that accumulated at the interface were collected, washed, and selected using anti-CD11c-conjugated MACS beads.
Small GTPase activity assay
The G-LISA small GTPase Activation Assay Biochemistry Combo Kit (RhoA, Rac1, cdc42) (Cytoskeleton, Colorado, USA) was used for the detection of activated form of RhoA, Rac1 and cdc42 (i.e. GTP-bound form). The experiments were carried out in accordance to the manufacturer protocol.
FITC-dextran uptake assay
To measure the phagocytic ability of DCs, the cells were incubated with FITC-dextran (70,000 MW, Invitrogen, Singapore). The BMDCs cultured with GM-CSF for 8 days were seeded on 12-well plates at a concentration of 1.0 × 10 6 cells/well. FITC-dextran was added to a final concentration of 0.5 mg/ml. The cells were incubated in either 4°C or 37°C for 30 min. After the incubation period, the cells were detached from plate by flushing with media and collected (centrifugation at 500g for 5 min), followed by washing in excess 1% BSA/PBS. After giving twice washing cells were immediately subjected for FACS analysis and the median florescence intensity (MFI) for FITC was measured.
Co-culture for antigen cross-presentation to CD8 + T cells
One μM of relevant peptide OVA257-264 or whole OVA was added to DC
(1 hr) and the excess unbound content was discarded. Subsequently, the OT-I CD8 + T cells were co-cultured with peptide-pulsed DCs with or without LPS. Unless otherwise stated, cells were co-cultured in triplicate wells using U-bottomed 96-well plates with a total of 1×10 5 DCs / ml (100ul total volume) at a 10:1 CD8 + T cell-to-DC ratio for 72 hr in a 37°C/5% CO2 incubator. CellTrace Violet (Invitrogen, USA) was used in accordance to manufacturer's protocol to label and measure proliferation of CD8 + T cells.
Cytokine detection
The levels of IL-12p40 and IL-12p70 in culture supernatants were measured using the mouse DuoSet ELISA development kit (R&D Systems, USA) according to the manufacturer instructions. Analysis was performed using a Luminex 100 plate reader (Qiagen, USA).
Flow cytometry
After 
Statistical analysis
The experimental significance between the treatments was calculated by performing analysis of variance (ANOVA) followed by Student's t test
